p62 Compound as p62 ligand composition for preventing improving or treating proteinopathies comprising the same

摘要

The present invention relates to a novel p62 ligand compound, a stereoisomer thereof, a solvate, a hydrate or a prodrug, a pharmaceutical or food composition for the prevention or treatment of a protein abnormal disease comprising it as an active ingredient, the p62 ligand according to the present invention The compound may be usefully used as a pharmaceutical composition for preventing, improving or treating various protein abnormal diseases by selectively removing proteins, organelles, and coagulation bodies in the body by activating intracellular autophages.